Ładuje się......
Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
BACKGROUND: The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the population. Many such assays have been launched by...
Zapisane w:
| Wydane w: | Int J Infect Dis |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872847/ https://ncbi.nlm.nih.gov/pubmed/33578017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.02.024 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|